Angiotensin II, the primary active hormone in the Renin-Angiotensin System is a major vasoconstrictor implicated in the cause of hypertension. Research efforts have focused in the treatment of disease by blocking its release and more recently by competing its action on AT 1 receptors. This approach generated in the pharmaceutical market, losartan, and other derivatives. To better understand the stereoelectronic requirements that lead to the molecular basis of hypertension the stereochemical features of angiotensin II and its antagonists are studied.
Keywords: Antihypertensive Drugs, Renin-Angiotensin System, AT1 Antagonists, Angiotensin, RENIN ANGIOTENSIN SYSTEM, ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, RENIN INHIBITORS, Captopril, Enlapril, Remikiren
Rights & PermissionsPrintExport
Published on: 01 March, 2012
Page: [207 - 217]